Table 3 Percentage of resistance in Escherichia coli by antimicrobial and country in 2012–2013

AT

142

14.08 (8.36–19.81)

[a,b]

142

5.63 (1.84–9.43)

[a, b]

142

11.97 (6.63–17.31)

[a]

142

5.63 (1.84–9.43)

[a, b]

142

14.08 (8.36–19.81)

[a, b]

142

8.45 (3.88–13.03)

[a]

78.87 (72.16–85.59)

[a]

BE

840

4.29 (2.92–5.66)

[c]

0

-

-

769

6.63 (4.87–8.39)

[b]

840

1.67 (0.80–2.53)

[c]

839

10.37 (8.31–12.43)

[a]

769^d

1.43^d (0.59–2.27)

-

85.05^d (82.52–87.57)

-

DK

206

2.88 (0.61–5.16)

[c]

208

4.33 (1.41–7.09)

[a, c]

208

2.88 (0.61–5.16)

[c]

208

1.92 (0.06–3.79)

[a, c]

208

8.17 (4.45–11.90)

[a, c]

208

2.88 (0.61–5.16)

[b]

88.94 (84.68–93.20)

[b, c]

FR

954

12.79 (10.67–15.91)

[a, d]

933

10.83 (8.83–12.82)

[b]

948

12.76 (10.64–14.89)

[a]

951

3.36 (2.22–4.51)

[a, d]

959

16.27 (13.93–18.60)

[b, d]

909

11.00 (8.97–13.04)

[a, c]

77.23 (74.50–79.95)

[a]

DE

153

11.76 (6.66–16.87)

[a, d]

152

11.84 (6.71–16.98)

[b, d]

153

16.34 (10.48–22.20)

[a, d]

153

1.96 (0.00–4.16)

[a, c, d]

153

17.65 (11.61–23.69)

[b, d, e]

152

8.55 (4.11–13.00)

[a]

67.76 (60.33–75.19)

[d]

EL

31

25.81 (10.40–41.21)

[b, d, e, f]

9

7R/2S

-

30

30.00 (13.60–46.40)

[d, e]

0

-

-

26

34.62 (16.33–52.90)

[e, f]

0

-

-

-

-

IT

69

26.09 (15.73–36.45)

[e, f]

69

24.64 (14.47–34.80)

[e]

69

31.88 (20.89–42.88)

[e]

69

14.49 (6.19–22.80)

[e]

69

28.99 (18.28–39.69)

[e, f]

69

28.99 (18.28–39.69)

[d]

63.77 (52.43–75.11)

[d, e, f]

NL

1461

10.81 (9.22–12.41)

[a]

1380

3.77 (2.76–4.77)

[a, c]

1457

4.94 (3.83–6.05)

[b, c]

81

3.70 (0.00–7.82)

[a, c, f]

1459

10.21 (8.66–11.77)

[a]

1380^d

2.25^d (1.46–3.03)

-

81.30^d (79.25-83.36)

-

PT

27

48.15 (29.30-66.99)

[e]

32

31.25 (15.19-47.31)

[e]

31

29.03 (13.05-45.01)

[d, e]

30

10.00 (0.00-20.74)

[b, d, e, f]

31

32.26 (15.80-48.71)

[e, f]

25

24.00 (7.26-40.74)

[c, d, e]

32.00 (13.71–50.29)

[g, h]

RS

3

2R/1S -

2

1R/1S

-

3

0R/3S

-

3

0R/3S

-

3

1R/2S

-

2

1MDR

-

1Full-S

-

ES

60

31.67 (19.90–43.44)

[e, f]

52

21.15 (10.05–32.25)

[d, e]

61

29.51 (18.06–40.95)

[e]

46

15.22 (4.84–25.60)

[b, e]

60

26.67 (15.48–37.86)

[e, f]

37

29.73 (15.00–44.46)

[d, e]

43.24 (27.28–59.21)

[e, g]

SE

2091

6.98 (5.89–8.07)

[g]

2082

0

[f]

2091

1.05 (0.61–1.49)

[f]

2091

0.19 (0.00–0.38)

[g]

2091

4.97 (4.04–5.91)

[c]

2082

0.24 (0.03–0.45)

[f]

90.2 (88.92–91.48)

[b, h]

CH

133

10.53 (5.31–15.74)

[a, g]

133

8.27 (3.59–12.95)

[b, c]

132

13.64 (7.78–19.49)

[a, d]

132

6.82 (2.52–11.12)

[b, d, e, f]

131

13.74 (7.85–19.64)

[a, d, g]

130

10.00 (4.84–15.16)

[a, e]

83.08 (76.63–89.52)

[a, c]

UK

143

21.68 (14.92–28.43)

[b, f]

143

20.98 (14.31–27.65)

[d, e]

143

11.89 (6.58–17.19)

[a]

92

6.52 (1.48–11.57)

[a, e, f]

142

21.13 (14.41–27.84)

[b, f, g]

89

15.56 (8.07–23.04)

[a, e]

67.78 (58.12–77.43)

[a, d, f]